{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:17:12Z","timestamp":1773955032392,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.1309\/ajcpqv4a7qaeefev","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T14:08:03Z","timestamp":1442585283000},"page":"601-606","source":"Crossref","is-referenced-by-count":36,"title":["The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis"],"prefix":"10.1093","volume":"144","author":[{"given":"Michele M.","family":"Tana","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakera","family":"Shums","sequence":"additional","affiliation":[{"name":"Inova Diagnostics, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Milo","sequence":"additional","affiliation":[{"name":"Inova Diagnostics, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[{"name":"Inova Diagnostics, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick S.","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongce","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay H.","family":"Hoofnagle","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"key\n\t\t\t\t20180602035132_b1-1440601","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180602035132_b2-1440601","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3748\/wjg.14.3328","article-title":"Etiopathogenesis of primary biliary cirrhosis","volume":"14","author":"Lleo","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180602035132_b3-1440601","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"Van de Water","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602035132_b4-1440601","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180602035132_b5-1440601","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/0016-5085(90)90488-M","article-title":"Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression","volume":"99","author":"Heseltine","year":"1990","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180602035132_b6-1440601","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","article-title":"Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression","volume":"25","author":"Van Norstrand","year":"1997","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180602035132_b7-1440601","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2002.05620.x","article-title":"Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?","volume":"97","author":"Joshi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180602035132_b8-1440601","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20180602035132_b9-1440601","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10446670410001722113","article-title":"Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis","volume":"11","author":"Benson","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"key\n\t\t\t\t20180602035132_b10-1440601","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180602035132_b11-1440601","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180602035132_b12-1440601","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180602035132_b13-1440601","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","article-title":"Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders","volume":"127","author":"Muratori","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20180602035132_b14-1440601","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180602035132_b15-1440601","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3748\/wjg.v16.i39.4938","article-title":"Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients","volume":"16","author":"Sfakianaki","year":"2010","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180602035132_b16-1440601","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180602035132_b17-1440601","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180602035132_b18-1440601","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gut.2004.040832","article-title":"Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?","volume":"54","author":"Bressler","year":"2005","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180602035132_b19-1440601","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180602035132_b20-1440601","doi-asserted-by":"crossref","first-page":"e101916","DOI":"10.1371\/journal.pone.0101916","article-title":"Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180602035132_b21-1440601","first-page":"359","article-title":"Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity [in Chinese]","volume":"21","author":"Tang","year":"2013","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key\n\t\t\t\t20180602035132_b22-1440601","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20180602035132_b23-1440601","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"key\n\t\t\t\t20180602035132_b24-1440601","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s005350170111","article-title":"The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples","volume":"36","author":"Kisand","year":"2001","journal-title":"J Gastroenterol"},{"key":"key\n\t\t\t\t20180602035132_b25-1440601","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180602035132_b26-1440601","first-page":"289","article-title":"Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis","volume":"59","author":"Aurangzeb","year":"2009","journal-title":"J Pak Med Assoc"},{"key":"key\n\t\t\t\t20180602035132_b27-1440601","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.23944","article-title":"Does change in AChR antibody level correlate with clinical change in MG?","volume":"49","author":"Sanders","year":"2014","journal-title":"Muscle Nerve"},{"issue":"suppl 9","key":"key\n\t\t\t\t20180602035132_b28-1440601","first-page":"1","article-title":"The rheumatoid factor in definite rheumatoid arthritis: an analysis of 1279 adult patients, with a follow-up study","author":"Sievers","year":"1965","journal-title":"Acta Rheumatol Scand Suppl"},{"key":"key\n\t\t\t\t20180602035132_b29-1440601","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/art.11445","article-title":"Prognostic markers of radiographic progression in early rheumatoid arthritis","volume":"50","author":"Goronzy","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180602035132_b30-1440601","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI105669","article-title":"The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus","volume":"46","author":"Rothfield","year":"1967","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180602035132_b31-1440601","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-9343(79)90529-1","article-title":"Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features","volume":"66","author":"Gladman","year":"1979","journal-title":"Am J Med"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/144\/4\/601\/25000379\/ajcpath144-0601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T14:53:11Z","timestamp":1567176791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/144\/4\/601\/1766728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,10,1]]},"published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpqv4a7qaeefev","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,10,1]]},"published":{"date-parts":[[2015,10,1]]}}}